Novo Nordisk India Private Limited, a active private limited company, was established on 07 February 1994 in Bangalore North, Karnataka, India. Engaging in diabetes care & endocrinology clinics within the trade sector, it holds CIN: U24111KA1994PTC015194. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹33.00 Cr and a paid-up capital of ₹26.50 Cr.
Formerly known as Novo Nordisk Pharma India Limited. It upholds a compliant status. Employing 1,533 professional, Its leadership includes Amit Kumar Das (Whole-Time Director), Vikrant Shrotriya (Managing Director), Thyagarajan Jayagovindan (Additional Director). Past directors included Raman Vitthal Shetty, Kasper Rosseuw Poulsen, Sebnem Avsar Tuna. It holds no open charges and ₹133.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Nxt 2, 1 & 2Nd Floor, Embassy Manyata Business Park, Nagavara Village, Kasaba Hobli, Bangalore North, Karnataka, 560045.
U24111KA1994PTC015194
015194
07 February 1994
₹33.00 Cr
₹26.50 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Novo Nordisk India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Kumar Das | Whole-Time Director | 22 Nov 2023 | Current |
| Vikrant Shrotriya | Managing Director | 03 Jan 2020 | Current |
| Thyagarajan Jayagovindan | Additional Director | 25 Jun 2025 | Current |
| Nanna Liborius Sjoerup | Additional Director | 25 Jun 2025 | Current |
| Annika Valla Broman | Director | 22 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Mar 2014 | Past |
| Pramod Abcsdd | Additional Director | 25 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 25 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 04 Jan 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novo Nordisk India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.4% increase. The company also saw a substantial improvement in profitability, with a 44.35% increase in profit. The company's net worth Soared by an impressive increase of 24.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Novo Nordisk India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,335,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2003 | Citi Bank N.A. | ₹50.00 Cr | Satisfied |
| 24 Mar 2003 | Citi Bank N.A. | ₹50.00 Cr | Satisfied |
| 07 Sep 1998 | Citi Bank N.A. | ₹15.00 Cr | Satisfied |
| 07 Sep 1998 | Citi Bank N.A. | ₹15.00 Cr | Satisfied |
| 18 Nov 1996 | Banque Nationale De Paris | ₹3.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Novo Nordisk India has a workforce of 1533 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Novo Nordisk India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Nordisk India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Annika Valla Broman was appointed as a Director was appointed as a Director on 22 Sep 2025 & has been associated with this company since 2 months 11 days . was documented.
Progress on Thyagarajan Jayagovindan was appointed as a Additional Director was appointed as a Additional Director on 25 Jun 2025 & has been associated with this company since 5 months 8 days . was documented.
The activity Nanna Liborius Sjoerup was appointed as a Additional Director was appointed as a Additional Director on 25 Jun 2025 & has been associated with this company since 5 months 8 days . was completed.
Novo Nordisk India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Juhi Pant was appointed as a Company Secretary was appointed as a Company Secretary on 03 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
Progress on Novo Nordisk India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The CIN of Novo Nordisk India Private Limited is U24111KA1994PTC015194.
Novo Nordisk India Private Limited is headquartered at Nxt 2, 1 & 2Nd Floor, Embassy Manyata Business Park, Nagavara Village, Kasaba Hobli, Bangalore North, Karnataka, 560045.
Novo Nordisk India Private Limited was incorporated on 07 February 1994.
The current directors of Novo Nordisk India Private Limited are
The primary industry of Novo Nordisk India Private Limited is Trade.
Novo Nordisk India Private Limited is unlisted.
The authorized capital of Novo Nordisk India Private Limited is ₹33.00 Cr, and the paid-up capital is ₹26.50 Cr.
The compliance status of Novo Nordisk India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX